Children's Cancer and Leukaemia Group
56
1
2
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
3.6%
2 terminated/withdrawn out of 56 trials
85.7%
-0.8% vs industry average
27%
15 trials in Phase 3/4
0%
0 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (56)
Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared
Role: collaborator
Granulocyte Transfusions After Umbilical Cord Blood Transplant
Role: collaborator
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma
Role: collaborator
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Role: collaborator
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Role: collaborator
Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
Role: collaborator
Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma
Role: collaborator
Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
Role: lead
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
Role: lead
Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only
Role: lead
Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
Role: lead
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
Role: lead
Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors
Role: lead
Quality of Life in Patients Who Have Undergone Previous Treatment for Primitive Neuroectodermal Tumors
Role: lead
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
Role: lead
Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye
Role: lead
Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma
Role: lead
Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain
Role: lead
Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma
Role: lead
Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma
Role: lead